COTI-2 reactivates mutant p53 and inhibits growth of triple-negative breast cancer cells

被引：0
|
作者：
Naoise C. Synnott
David O’Connell
John Crown
Michael J. Duffy
机构：
[1] University College Dublin,UCD School of Medicine, Conway Institute of Biomolecular and Biomedical Research
[2] University College Dublin,UCD School of Biomolecular & Biomedical Science
[3] St. Vincent’s University Hospital,Department of Medical Oncology
[4] St. Vincent’s University Hospital,UCD Clinical Research Centre
来源：
Breast Cancer Research and Treatment | 2020年 / 179卷
关键词：
p53; TP53; COTI-2; Triple-negative breast cancer; Treatment; APR-246;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：47 / 56
页数：9
相关论文
共 50 条
  • [21] Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer
    Zhang, Qian-Qian
    Chen, Jian
    Zhou, Da-Lei
    Duan, You-Fa
    Qi, Cui-Ling
    Li, Jiang-Chao
    He, Xiao-Dong
    Zhang, Min
    Yang, Yong-Xia
    Wang, Lijing
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2017, 13 (04): : 471 - 479
  • [22] Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K
    Liu, Jeff C.
    Voisin, Veronique
    Wang, Sharon
    Wang, Dong-Yu
    Jones, Robert A.
    Datti, Alessandro
    Uehling, David
    Al-awar, Rima
    Egan, Sean E.
    Bader, Gary D.
    Tsao, Ming
    Mak, Tak W.
    Zacksenhaus, Eldad
    EMBO MOLECULAR MEDICINE, 2014, 6 (12) : 1542 - 1560
  • [23] Downregulation of RIP140 in triple-negative breast cancer inhibits the growth and proliferation of cancer cells
    Yu, Xiao-Hong
    Xue, Xiaodong
    Zhu, Xun
    Li, Xia
    ONCOLOGY LETTERS, 2018, 15 (06) : 8784 - 8788
  • [24] Targeting mutant p53 with arsenic trioxide: A preclinical study focusing on triple negative breast cancer
    Rajaram, Subhasree
    Synnott, Naoise C.
    Crown, John
    Madden, Stephen F.
    Duffy, Michael J.
    TRANSLATIONAL ONCOLOGY, 2024, 46
  • [25] Efp promotes growth of triple-negative breast cancer cells
    Sato, Wataru
    Ikeda, Kazuhiro
    Gotoh, Noriko
    Inoue, Satoshi
    Horie, Kuniko
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 624 : 81 - 88
  • [26] PRIMA-1 inhibits growth of breast cancer cells by re-activating mutant p53 protein
    Liang, Yayun
    Besch-Williford, Cynthia
    Hyder, Salman M.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (05) : 1015 - 1023
  • [27] Mutant p53 mediates survival of breast cancer cells
    Lim, L. Y.
    Vidnovic, N.
    Ellisen, L. W.
    Leong, C-O
    BRITISH JOURNAL OF CANCER, 2009, 101 (09) : 1606 - 1612
  • [28] Mutant p53 mediates survival of breast cancer cells
    L Y Lim
    N Vidnovic
    L W Ellisen
    C-O Leong
    British Journal of Cancer, 2009, 101 : 1606 - 1612
  • [29] p53 Missense Mutation is Associated with Immune Cell PD-L1 Expression in Triple-Negative Breast Cancer
    Xing, Ai-Yan
    Liu, Long
    Liang, Ke
    Wang, Bin
    CANCER INVESTIGATION, 2022, 40 (10) : 879 - 888
  • [30] Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival
    Thike, Aye A.
    Tan, Puay H.
    Ikeda, Murasaki
    Iqbal, Jabed
    HISTOPATHOLOGY, 2016, 68 (05) : 702 - 712
12345